ClinicalTrials.Veeva

Menu

Sickle Cell Anemia and Cerebral Microcirculation : Multimodal Exploration (DREAM²)

I

Imagine Institute

Status

Completed

Conditions

Sickle Cell Disease

Treatments

Procedure: Physical exams and blood analyzes

Study type

Observational

Funder types

Other

Identifiers

NCT02909283
IMIS2014-04

Details and patient eligibility

About

The aim of this study is to evaluate determinants of cerebral oxygenation and perfusion at the microcirculatory level in children with sickle cell anemia (SCA) using combined novel investigational tools: Arterial Spin Labeling (ASL) perfusion MR (Magnetic Resonnance) imaging, brain Near Infra-Red Spectroscopy (NIRS) and red blood cell (RBC) rheological properties.

Full description

The investigators hypothesize that brain perfusion and/or oxygenation modifications may be evidenced in SCA children who have no microarteriopathy and may correlate with hemorheological abnormalities and impaired vasomotion. A multimodal approach designed to study a. cerebral perfusion and oxygenation, b. flow motion properties and c. blood rheological parameters might help to describe the different processes involved in cerebral ischemia.

Enrollment

64 patients

Sex

All

Ages

6 to 16 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • SS or S-beta° genotype;
  • age 6-16 years;
  • steady state;
  • normal TCD (Transcranial Doppler);
  • parental study approval and written informed consent.

Exclusion criteria

  • SC, Sbeta+, SD Punjab genotype
  • history of overt stroke,
  • intracranial or cervical arterial stenosis,
  • abnormal TCD at the time of the study.

Trial design

64 participants in 1 patient group

Sickle cell disease patients
Description:
Physical exams and blood analyzes
Treatment:
Procedure: Physical exams and blood analyzes

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems